Triple-Negative Breast Cancer (TNBC) Active Not Recruiting Phase 2 Trials for Carboplatin (DB00958)

Also known as: Triple-negative Breast Cancer

IndicationStatusPhase
DBCOND0067309 (Triple-Negative Breast Cancer (TNBC))Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02978716Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)Treatment
NCT01372579Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer PatientsTreatment
NCT01525966Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast CancerTreatment
NCT01818063Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast CancerTreatment
NCT02413320Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast CancerTreatment